PharmaCorp Rx Inc. (TSXV:PCRX)

PharmaCorp Rx Revenue

PharmaCorp Rx had revenue of 7.73M CAD in the quarter ending June 30, 2026, with 75.81% growth. This brings the company's total for the last twelve months to 27.41M, up 97.10% year-over-year. In the year 2025, PharmaCorp Rx had annual revenue of 20.89M with 260.57% growth. That makes PharmaCorp Rx the 34,070th largest company in the world by revenue and 618th in Canada.

• Revenue (ttm): 27.41M
• Revenue Growth: +97.10%
• P/S Ratio: 2.84
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 77.81M

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Wholly Owned Pharmacies 14.66M 70.1%
• Non-wholly Owned Pharmacies 6.24M 29.9%

Fiscal year ended Dec 31, 2025 See the full PharmaCorp Rx breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	20.89M	15.10M	260.57%
Dec 31, 2024	5.79M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 20, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error